Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

15

Revenue 2017

Neulasta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Neulasta was produced by Amgen.

Sandoz finally wins FDA approval for Neulasta biosimilar

Sandoz finally wins FDA approval for Neulasta biosimilar

Amgen had a lucky break when the FDA initially rejected Sandoz’ Neulasta biosimilar back in 2016, as the US market accounts for the bulk of its sales for this medicine. ... Neulasta had been one of Amgen’s biggest commercial products, but has been 

Amgen exits neuroscience R&D to focus on growth areas

Amgen exits neuroscience R&D to focus on growth areas Away from its neuroscience news, Amgen reported a 3% decline in revenues to $5.74bn on its third-quarter update, with red blood cell stimulators Neupogen and Neulasta both plummeting around

Amgen buys Danish partner Nuevolution for $167m

Amgen buys Danish partner Nuevolution for $167m The company is starting to face biosimilar competition for white blood cell stimulator Neulasta (pegfilgrastim) as well as generic encroachment on Sensipar (cinacalcet) for secondary hyperparathyroidism, which together accounted for around

Amgen CEO says Aimovig is “one of most successful launches”

Amgen CEO says Aimovig is “one of most successful launches” Overall, Amgen posted a 2% rise in revenues to $5.78bn in the quarter, despite pressure on older drugs like while blood cell booster Neulasta (pegfilgrastim) which showed the first signs

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals and ERA Consulting’s Udenyca (pegfilgrastim), both alternatives to Amgen’s Neulasta  brand for neutropenia and febrile neutropenia due to chemotherapy.

1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...